Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

2.04
Delayed Data
As of Feb 24
 -0.03 / -1.45%
Today’s Change
1.98
Today|||52-Week Range
4.33
-20.00%
Year-to-Date

Today’s Trading

Previous close2.07
Today’s open2.06
Day’s range2.03 - 2.13
Volume123,770
Average volume (3 months)199,437
Market cap$86.2M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-853.85%
Earnings growth (this year)-1.02%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.90%
P/E ratioNM
Price/Sales2,402.53
Price/Book0.50

Competitors

 Today’s
change
Today’s
% change
AFMDAffimed NV0.000.00%
GEMPGemphire Therapeutic...+0.17+1.88%
SYNSynthetic Biologics ...+0.01+1.17%
SBPHSpring Bank Pharmace...-0.12-1.32%
Data as of 4:02pm ET, 02/24/2017

Financials

Last reporting dateFebruary 27, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$70.0K
Annual profit (last year)-$41.3M
Net profit margin-58,956.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Sherman
Chief Financial Officer
Michael T. Andriole
Corporate headquarters
West Lafayette, Indiana

Forecasts


Search for Jobs